Novo Nordisk shares pop on early-stage weight loss drug trial results
Read more at CNBC
-
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - 6h -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - 9h -
Weight-loss drugs may boost health in many ways, say researchers
New weight-loss drugs have broad health benefits but also come with risks, researchers warn.BBC News - 4d -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - Jan. 17 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand
Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’Financial Times - Jan. 9 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8 -
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the "entitlement" some ...The Hill - Jan. 2
More from CNBC
-
Alphabet shares close above $200 for first time on split-adjusted basis
Investors are growing more bullish on Alphabet as the company speeds up its AI development.CNBC - 1h -
Trump recommends ending FEMA ahead of California fire site visit
President Donald Trump will visit California to see the damage caused by wildfires around Los Angeles. FEMA has been involved in response efforts there.CNBC - 28m -
Target rolls back DEI initiatives, the latest big company to retreat
Target joins Walmart, Meta, McDonald's and a wave of other major companies pulling back on DEI programs.CNBC - 3h -
Zuckerberg sets Meta's AI targets for the year, expects to spend $60 billion on growth
Meta CEO Mark Zuckerberg announced the company plans to invest around $60 billion to $65 billion in capital expenditures this yearCNBC - 2h -
Venture Global closes below IPO price in disappointing debut despite Trump's support of LNG industry
"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sabel told CNBC in an interview Friday.CNBC - 2h
More in Business
-
Trump recommends ending FEMA ahead of California fire site visit
President Donald Trump will visit California to see the damage caused by wildfires around Los Angeles. FEMA has been involved in response efforts there.CNBC - 28m -
New Yorkers Could Use Paid Sick Leave to Care for Pets Soon
Legislation could let New Yorkers take paid sick leave for their pets and service animals.Inc. - 32m -
What’s Your Apple Juice?
Make it a goal for this year to recharge before it’s too late.Inc. - 38m -
Target joins Walmart in pulling back on DEI. But this big retailer and its shareholders are staying the course.
Target said that it was ending its diversity, equity and inclusion goals as it tries to align itself with an “evolving external landscape.”MarketWatch - 45m -
Why Age-Gating Social Media is a No-Brainer
This policy has worked with alcohol and tobacco—let’s try it with social media.Inc. - 58m